UF Health Cancer Center Support Grant - Training Navigator Supplement

佛罗里达大学健康癌症中心支持补助金 - 培训导航补充

基本信息

  • 批准号:
    10892335
  • 负责人:
  • 金额:
    $ 19.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-06-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

The University of Florida Health Cancer Center (UFHCC) recognizes that achieving health equity requires inclusive education, training, recruitment, retention, and promotion of the next generation of cancer researchers. Therefore, this Administrative Supplement application aims to recruit and develop a cadre of independent researchers prepared to address cancer disparities in our catchment area. This supplement will enhance the synergistic impact of CaRTEC, DEI, and the Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center by focusing on developing underrepresented minority (URM) pre-doc, post-doc, and early-stage investigators (ESIs). To expand upon the success of CaRTEC and CaRE2, and achieve their long-term goal of improving training outcomes of URM trainees and ESIs, a Training Navigator Team (TNT) will be implemented to 1) bridge activities between CaRTEC, DEI, and CaRE2 programs at the UFHCC; 2) facilitate the entry of URM into the cancer research training pipeline; and 3) prepare trainees and ESIs to pursue career development opportunities provided by the Center to Reduce Cancer Health Disparities CURE program and beyond. This collaborative effort seeks to build upon the successes of each program through the following objectives: 1) implement a TNT to attract, recruit, and support competitive underrepresented trainees and ESIs, and facilitate their entry into NIH-supported pathway programs at the UFHCC and the attainment of NCI funding; 2) provide professional preparation and networking opportunities for scholars through grant writing and technical assistance workshops (TAWs); and 3) monitor, track, and evaluate the progress and productivity of trainees and ESIs. In particular, the TNT will help recruit URM trainees regionally, from partnering MSIs, as well as national conferences to exhibit the work of minoritized undergraduate researchers. In addition, a series of 5 training assistance workshops (TAWs) will be developed to prepare trainees and ESIs to pursue CURE funding. All TAWs will be recorded and content will be used to develop an innovative hybrid and asynchronous course that will be offered through the University's web-based learning management system. Metrics will be tracked on new cancer-relevant awards and publications, proposals and supplements submitted and the corresponding funding rate, and mentorship activities for trainees. Evaluations using the CPACHE U54 Research Education Shared Measures Toolkit will also determine the impact of proposed activities on funding and career development. This application is significant because it will increase the number of URM trainees at the UFHCC, increase the awareness around URM- and cancer disparities-relevant funding, and improve the capacity for URM UFHCC trainees to pursue external funding. This program will be impactful because it will help recruit >15 post-bacs, pre-docs, post-docs, and fellows and will engage >40 pre-docs, post-docs, fellows, and ESIs in TAWs who will submit a total of 10 CURE-supported applications in 2023-2024.
佛罗里达大学卫生癌症中心(UFHCC)认识到实现健康公平需要 下一代癌症研究人员的全包教育,培训,招聘,保留和促进。 因此,这种行政补充申请旨在招募和发展独立的干部 研究人员准备解决我们集水区的癌症差异。这种补充将增强 Cartec,Dei和佛罗里达 - 加利福尼亚癌症研究,教育和参与的协同影响 (CARE2)卫生平等中心通过专注于发展代表性不足的少数族裔(URM)大多数情况前,大多数 和早期研究人员(ESI)。扩大Cartec和Care2的成功,并实现他们的 改善URM受训者和ESI的培训成果的长期目标,培训导航员团队(TNT)将 在UFHCC的Cartec,dei和Care2计划之间实施1)桥梁活动; 2)便利 URM进入癌症研究培训管道; 3)准备学员和ESI以追求职业 中心提供的发展机会,以减少癌症健康差异治疗计划和 超过。这种协作努力旨在通过以下方式建立每个计划的成功 目标:1)实施TNT来吸引,招募和支持竞争性不足的学员和ESI, 并促进他们在UFHCC进入NIH支持的途径计划并获得NCI资金; 2)通过赠款写作和技术为学者提供专业的准备和网络机会 协助讲习班(TAW); 3)监视,跟踪和评估受训者的进步和生产率 Esis。特别是,TNT将帮助从合作MSI和国家 会议展示少数化本科研究人员的工作。此外,一系列5培训 将开发援助研讨会(TAW),以准备学员和ESI来寻求治疗资金。全部 将记录TAW,并将内容用于开发创新的混合和异步过程,该过程 将通过大学的基于网络的学习管理系统提供。指标将在新的 与癌症相关的奖项和出版物,提交的提案和补品以及相应的资金 对学员的费率和指导活动。使用CPACHE U54研究教育共享的评估 措施工具包还将确定拟议活动对资金和职业发展的影响。这 应用很重要,因为它将增加UFHCC的URM受训者的数量,增加 意识到与URM和癌症差异相关的资金,并提高UFHCC的能力 受训人员寻求外部资金。该计划将有影响 前卫星,doc和研究员,将在Taws中与40个> 40次> 40次前卫星,后者,研究员和ESI互动 在2023 - 2024年,总共提交10份治疗支持的申请。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Histone mutations in cancer.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan D. Licht其他文献

HLA-DR, CD33<sup>+</sup>, CD56<sup>+</sup>, CD16<sup>-</sup> Myeloid/Natural Killer Cell Acute Leukemia: A Previously Unrecognized Form of Acute Leukemia Potentially Misdiagnosed as French-American-British Acute Myeloid Leukemia-M3
  • DOI:
    10.1182/blood.v84.1.244.244
  • 发表时间:
    1994-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    Amy A. Scott;David R. Head;Kenneth J. Kopecky;Frederick R. Appelbaum;Karl S. Theil;Michael R. Grever;l-Ming Chen;Michael H. Whittaker;Barbara B. Griffith;Jonathan D. Licht;Samuel Waxman;Margaret M. Whalen;Arthur D. Bankhurst;Lynn C. Richter;Thomas M. Grogan;Cheryl L. Willman
  • 通讯作者:
    Cheryl L. Willman
Compound Loss of <em>Dnmt3a</em> and <em>Kmt2c</em> in Myeloid Malignancies
  • DOI:
    10.1182/blood-2023-189411
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Prabhjot Kaur;Cassandra Berntsen;James Leonard;Daniil Shabashvili;Qingchen Yuan;Bowen Yan;Richard Lynn Bennett;Alberto Riva;Jonathan D. Licht;Olga A. Guryanova
  • 通讯作者:
    Olga A. Guryanova
Synergistic Effect of Trifluridine and PARPi Combination in Targeting <em>TP53</em>-Mutated AML
  • DOI:
    10.1182/blood-2024-201781
  • 发表时间:
    2024-11-05
  • 期刊:
  • 影响因子:
  • 作者:
    Phani Krishna Parcha;Vivek M. Shastri;Jonathan D. Licht;Jatinder K. Lamba
  • 通讯作者:
    Jatinder K. Lamba
Sprouty1 Controls Genitourinary Development via its N-Terminal Tyrosine.
Sprouty1 通过其 N 端酪氨酸控制泌尿生殖系统的发育。
  • DOI:
    10.1681/asn.2018111085
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Vaquero;S. Cuesta;C. Anerillas;Gisela Altés;J. Ribera;M. Albert Basson;Jonathan D. Licht;J. Egea;M. Encinas
  • 通讯作者:
    M. Encinas
Activating <em>NSD2</em> Mutations Drive Oncogenic Reprogramming By Disturbing Epigenetic Landscape in Mantle Cell Lymphoma
  • DOI:
    10.1182/blood-2023-189748
  • 发表时间:
    2023-11-02
  • 期刊:
  • 影响因子:
  • 作者:
    Jianping Li;Marta Kulis;Alberto Riva;Heidi Casellas Román;Daphne Dupere-Richer;Monica Clerio;Melanie L. Trejo;Michael Menes;Anthony Joseph Lamberto;Amin Sobh;Charlotte Leonie Kaestner;Richard Lynn Bennett;Iñaki I. Martin Subero;Jonathan D. Licht
  • 通讯作者:
    Jonathan D. Licht

Jonathan D. Licht的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan D. Licht', 18)}}的其他基金

Exploring microRNA degradation in T-cell acute lymphoblastic leukemia
探索 T 细胞急性淋巴细胞白血病中的 microRNA 降解
  • 批准号:
    10717486
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
University of Florida Health Cancer Center Support Grant
佛罗里达大学健康癌症中心支持补助金
  • 批准号:
    10625750
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
Developmental Funds
发展基金
  • 批准号:
    10625759
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
Leadership, Planning, and Evaluation
领导、规划和评估
  • 批准号:
    10625761
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma
定义和针对黑色素瘤中表观遗传可塑性驱动的耐药性和免疫逃逸
  • 批准号:
    10666665
  • 财政年份:
    2022
  • 资助金额:
    $ 19.59万
  • 项目类别:
KDM6A mutation as an epigenetic driver of multiple myeloma
KDM6A 突变作为多发性骨髓瘤的表观遗传驱动因素
  • 批准号:
    10229675
  • 财政年份:
    2020
  • 资助金额:
    $ 19.59万
  • 项目类别:
2019 Cancer Genetics and Epigenetics GRC/GRS
2019年癌症遗传学和表观遗传学GRC/GRS
  • 批准号:
    9754282
  • 财政年份:
    2019
  • 资助金额:
    $ 19.59万
  • 项目类别:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
MMSET 在淋巴恶性肿瘤发病机制和进展中的作用
  • 批准号:
    9330809
  • 财政年份:
    2016
  • 资助金额:
    $ 19.59万
  • 项目类别:
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy
MMSET 在淋巴恶性肿瘤发病机制和进展中的作用
  • 批准号:
    9759647
  • 财政年份:
    2016
  • 资助金额:
    $ 19.59万
  • 项目类别:
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
癌症中染色质的时空组织和信息传递
  • 批准号:
    8866966
  • 财政年份:
    2015
  • 资助金额:
    $ 19.59万
  • 项目类别:

相似海外基金

Identifying how alcohol-evoked changes in neural firing affect systems level computations during decision-making
确定酒精引起的神经放电变化如何影响决策过程中的系统级计算
  • 批准号:
    10766877
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
Facility Management, Maintenance and Operation Core
设施管理、维护和运营核心
  • 批准号:
    10793908
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - EIS
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
  • 批准号:
    10686546
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
CNS Effects of Alcohol: Cellular Neurobiology
酒精对中枢神经系统的影响:细胞神经生物学
  • 批准号:
    10834659
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
Programs for the Training and Advancement of the Next GENeration of Native Researchers in Genetics, Ethics and Society
下一代本土遗传学、伦理学和社会研究人员的培训和提升计划
  • 批准号:
    10841760
  • 财政年份:
    2023
  • 资助金额:
    $ 19.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了